Who has invested in Link Cell Therapies?

Johnson & Johnson are named among the investors backing Link Cell Therapies.

Link Cell Therapies Funding: $92M Raised, Series A (2024)

Link Cell Therapies funding overview

Link Cell Therapies has raised $92M in total disclosed funding. That places its disclosed total in the $25M–$100M range. Its most recent disclosed round is a Series A announced in December 2024. The round record for Link Cell Therapies runs through 2024; nothing later has been disclosed. Investors on record include Johnson & Johnson.

Link Cell Therapies at a glance

Total raised: $92M
Latest round: Series A
Latest round date: December 2024
Notable investors: Johnson & Johnson

Frequently asked about Link Cell Therapies funding

How much has Link Cell Therapies raised?: Link Cell Therapies has raised $92M in total disclosed funding across the rounds on record.
Who has invested in Link Cell Therapies?: Johnson & Johnson are named among the investors backing Link Cell Therapies.
What was the latest Link Cell Therapies funding round?: The most recent disclosed round is a Series A, announced in December 2024.
Where is Link Cell Therapies based?: No headquarters location is disclosed for Link Cell Therapies.
When did Link Cell Therapies last raise?: The last disclosed Link Cell Therapies round closed in December 2024 at Series A.

Round data for Link Cell Therapies is compiled from public filings and announcements; blank fields mean nothing has been disclosed rather than nothing exists. Continue with the companies and backer lists below.

Link Cell Therapies Funding: $92M Raised, Series A (2024)

Link Cell Therapies funding overview

Link Cell Therapies at a glance

Frequently asked about Link Cell Therapies funding

Companies related to Link Cell Therapies (39)

Browse related funding lists (4)